Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription


1 Biol Psychiatry
2 Psychiatry Res
3 Psychol Med
1 Schizophr Res

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Biol Psychiatry

  1. GRENT-'T-JONG T, Gajwani R, Gross J, Gumley AI, et al
    40-Hz Auditory Steady-State Responses Characterize Circuit Dysfunctions and Predict Clinical Outcomes in Clinical High-Risk for Psychosis Participants: A Magnetoencephalography Study.
    Biol Psychiatry. 2021 Mar 23. pii: S0006-3223(21)01177.
    PubMed         Abstract available

    Psychiatry Res

  2. CASADO-ORTEGA A, Vila-Badia R, Butjosa A, Del Cacho N, et al
    Social cognition and its relationship with sociodemographic, clinical, and psychosocial variables in first-episode psychosis.
    Psychiatry Res. 2021;302:114040.
    PubMed         Abstract available

  3. KELLY DL, Claxton A, Bidollari I, Du Y, et al
    Analysis of prolactin and sexual side effects in patients with schizophrenia who switched from paliperidone palmitate to aripiprazole lauroxil.
    Psychiatry Res. 2021;302:114030.
    PubMed         Abstract available

    Psychol Med

  4. STRAUSS GP, Bartolomeo LA, Luther L
    Reduced willingness to expend effort for rewards is associated with risk for conversion and negative symptom severity in youth at clinical high-risk for psychosis.
    Psychol Med. 2021 Jun 14:1-8. doi: 10.1017/S003329172100204.
    PubMed         Abstract available

  5. SIAFIS S, Davis JM, Leucht S
    Antipsychotic drugs: from 'major tranquilizers' to Neuroscience-based-Nomenclature.
    Psychol Med. 2021;51:522-524.

  6. MONCRIEFF J, Cohen D
    Antipsychotics as particular types of sedatives.
    Psychol Med. 2021;51:521.

    Schizophr Res

  7. METZAK PD, Farris MS, Placsko T, Braun A, et al
    Social functioning and brain imaging in individuals at clinical high-risk for psychosis: A systematic review.
    Schizophr Res. 2021;233:3-12.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.